Ifeoma Ugonabo

Dr. Ifeoma Ugonabo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAsra K Butt
Asra K Butt
DADeya Alkhatib
Deya Alkhatib
IPIssa Pour-Ghaz
Issa Pour-Ghaz
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
OAOmar Al-Taweel
Omar Al-Taweel
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy resulting from a mutation in one of several cardiac sarcomeric proteins

Verified
Journal Article
Open access
PDF file
DADeya Alkhatib
Deya Alkhatib
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
IPIssa Pour-Ghaz
Issa Pour-Ghaz
ABAsra K Butt
Asra K Butt
OAOmar Al-Taweel
Omar Al-Taweel
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Heart failure (HF) therapeutics have advanced significantly over the past few years

Verified
Journal Article
Open access
PDF file
IPIssa Pour-Ghaz
Issa Pour-Ghaz
DADeya Alkhatib
Deya Alkhatib
SISakiru Oyetunji Isa
Sakiru Oyetunji Isa
OAOmar Al-Taweel
Omar Al-Taweel
IUIfeoma Ugonabo
Ifeoma Ugonabo
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
One of the major risk factors for coronary atherosclerosis is the gradual formation and maturation of coronary atherosclerotic plaque (CAP)